Compare ImmunityBio Inc. Common Stock (IBRX) vs Newmont Corporation (NEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ImmunityBio Inc. Common Stock vs Newmont Corporation — how do they compare? ImmunityBio Inc. Common Stock trades at $10 (market cap $10.33B), while Newmont Corporation trades at $117.8 (market cap $119.64B). The key difference: Newmont Corporation is far larger — about 11.6× ImmunityBio Inc. Common Stock's market cap, and Newmont Corporation pays a 0.92% dividend while ImmunityBio Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 0 Days and Newmont Corporation for 58 Days on average.
| IBRX | NEM | |
|---|---|---|
Market Cap | $10.33B | $119.64B |
Volume | 11,745,198 | 4,343,460 |
Sector | Health | Basic Materials |
52-Week High | $11.55 | $135.14 |
52-Week Low | $1.98 | $78.63 |
Typical Hold Time | 0 Days | 58 Days |
Enterprise Value | $10.79B | $116.23B |
Dividend Yield | — | 0.92% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
NEM trades at $115.55, down 0.72% on the day, with a bearish technical signal but strong fundamentals. Recent earnings beats and record free cash flow of $5.3B in H1 2026 highlight operational strength. The stock is supported by a 75.68% analyst buy rating and a consensus price target of $136.83, though it faces near-term resistance at $116.
The outlook remains positive given robust profitability and growth, but risks include gold price volatility and execution of per-share growth targets. Upside potential exists if the company continues to exceed earnings expectations and maintains its cash flow momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →About Newmont Corporation
Newmont Corp is primarily a gold producer with operations and/or assets in the United States, Canada, Mexico, Dominican Republic, Peru, Suriname, Argentina, Chile, Australia, and Ghana. It is also engaged in the production of copper, silver, lead and zinc. The company's operations are organized in five geographic regions: North America, South America, Australia, Africa and Nevada.
Read more on NEM →
